San Diego, CA, United States of America

Peter S Tobias


Average Co-Inventor Count = 3.3

ph-index = 6

Forward Citations = 84(Granted Patents)


Location History:

  • Encinitas, CA (US) (1993 - 2002)
  • San Diego, CA (US) (1998 - 2008)

Company Filing History:


Years Active: 1993-2008

Loading Chart...
17 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Peter S. Tobias

Introduction

Peter S. Tobias is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 17 patents to his name, Tobias has established himself as a key figure in medical research and innovation.

Latest Patents

One of his latest inventions is the development of hybrid cells producing monoclonal anti-CD14 antibodies. This invention provides hybridoma cell lines that produce monoclonal antibodies which inhibit CD14 mediated cell activation. The monoclonal antibodies produced by these cell lines are useful for detecting the presence of cell surface and soluble CD14 in a sample. Additionally, chimeric and CDR grafted antibodies generated from these monoclonal antibodies are also provided. Pharmaceutical compositions containing these biological compositions are useful for treating and preventing disorders associated with CD14 mediated cell activation, such as sepsis.

Another significant patent involves monoclonal antibodies that are immunoreactive with lipopolysaccharide binding protein (LBP). This invention concerns a method of treating LBP-mediated LPS-induced myeloid cell activation by administering a therapeutically effective amount of an anti-LBP monoclonal antibody molecule. A therapeutic composition comprising anti-LBP antibody molecules in a pharmaceutically acceptable excipient is also contemplated.

Career Highlights

Throughout his career, Peter S. Tobias has worked with esteemed institutions, including The Scripps Research Institute. His work has had a profound impact on the field of immunology and therapeutic development.

Collaborations

Tobias has collaborated with notable colleagues such as Richard J. Ulevitch and John C. Mathison. Their combined expertise has contributed to advancements in the understanding and treatment of various medical conditions.

Conclusion

Peter S. Tobias is a distinguished inventor whose work in monoclonal antibodies has paved the way for innovative treatments in medicine. His contributions continue to influence the field and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…